ADIAL PHARMACEUTICALS INC (ADIL) Stock Analyst Ratings
NASDAQ:ADIL - Nasdaq - US00688A2050 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to ADIL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.63. This target is 906.83% above the current price.
ADIL was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ADIL.
In the previous month the buy percentage consensus was at a similar level.
ADIL was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-14 | Rodman & Renshaw | Initiate | Buy |
| 2023-07-11 | Brookline Capital | Reiterate | Buy -> Buy |
| 2022-08-17 | Maxim Group | Downgrade | Buy -> Hold |
| 2021-10-13 | Brookline Capital | Initiate | Buy |
| 2021-06-29 | Litchfield Hills | Initiate | Buy |